BASIC FIBROBLAST GROWTH-FACTOR IN A PORCINE MODEL OF CHRONIC MYOCARDIAL-ISCHEMIA - A COMPARISON OF ANGIOGRAPHIC, ECHOCARDIOGRAPHIC AND CORONARY FLOW PARAMETERS
Jj. Lopez et al., BASIC FIBROBLAST GROWTH-FACTOR IN A PORCINE MODEL OF CHRONIC MYOCARDIAL-ISCHEMIA - A COMPARISON OF ANGIOGRAPHIC, ECHOCARDIOGRAPHIC AND CORONARY FLOW PARAMETERS, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 385-390
Recently, a number of growth factors including basic fibroblast growth
factor (bFGF) have been shown to promote angiogenesis in vivo. In thi
s study, we evaluated dose-dependent effect of bFGF administration in
the setting of chronic myocardial ischemia. A total of 18 Yorkshire pi
gs subjected to ameroid occluder placement on the left circumflex arte
ry were randomized to treatment with 10 (n = 6) or 100 mu g (n = 5) of
bFGF incorporated into heparin-alginate microspheres or inactive cont
rol pellets (n = 7). Eight weeks later, all animals underwent angiogra
phic evaluation of collateral development as well as studies of corona
ry flow and global and regional left ventricular function. Both bFGF g
roups had significantly higher angiographic collateral index, TIMI flo
w scores and coronary flow in the ameroid-compromised territory compar
ed with controls. Left ventricular function studies demonstrated impro
ved global and regional function in both fibroblast growth factor grou
ps with significantly better preservation of regional wall motion in h
igh dose (100 mu g) bFGF animals. We conclude that local perivascular
delivery of bFGF results in significant improvement in myocardial func
tion in the setting of chronic myocardial ischemia.